The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Nazarov V.D.

Tsentr rassejannogo skleroza i drugih demielinizirujuschih zabolevaniĭ Gorodskoĭ klinicheskoĭ bolnitsy №31, Sankt-Peterburg

Makshakov G.S.

Tsentr rassejannogo skleroza i drugih demielinizirujuschih zabolevaniĭ Gorodskoĭ klinicheskoĭ bolnitsy №31, Sankt-Peterburg

Mazing A.V.

First Saint-Petersburg Pavlov State Medical University, Saint-Petersburg

Surkova E.A.

GBOU VPO «Pervyj Sankt-Peterburgskij gosudarstvennyj meditsinskij universitet im. akad. I.P. Pavlova» Minzdrava Rossii, Sankt-Peterburg, Rossija

Krasnov V.S.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova, kafedra nevrologii s klinikoĭ;
Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova, Sankt-Peterburg

Shumilina M.V.

Akademicheskaia gruppa akad. RAMN A.A. Skoromtsa (Universitet Émori - Atlanta, SShA);
Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Evdoshenko E.P.

Sankt-Peterburgskoe GBUZ "Gorodskaia klinicheskaia bol'nitsa #31", Sankt-Peterburgskiĭ gorodskoĭ Tsentr rasseiannogo skleroza i autoimmunnykh zabolevaniĭ, Sankt-Peterburg

Lapin S.V.

Pavlov First St. Petersburg State Medical University, Russia, 197022, St. Petersburg, St. Leo Tolstoy 6/8

Emanuel’ V.L.

Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First Saint Petersburg State Medical University» of the Ministry of Healthcare of the Russia, Saint Petersburg, Russia

Skoromets A.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis

Authors:

Nazarov V.D., Makshakov G.S., Mazing A.V., Surkova E.A., Krasnov V.S., Shumilina M.V., Totolian N.A., Evdoshenko E.P., Lapin S.V., Emanuel’ V.L., Skoromets A.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2‑2): 60‑65

DOI: 10.17116/jnevro20171172260-65

Views: 2228

Downloaded: 32

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Nazarov VD, Makshakov GS, Mazing AV, et al. . Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2‑2):60‑65. (In Russ.)
https://doi.org/10.17116/jnevro20171172260-65

Подписка 2025 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Limi­tations and possibilities of treatment of patients with infe­rtility against the background of multiple scle­rosis disease during the COVID-19 pandemic. Russian Bulletin of Obstetrician-Gynecologist. 2024;(1):83-87
Vali­dation of e-version of Russian-language expa­nded disa­bility status scale (EDSS) for patients with multiple scle­rosis in the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2024;(1):9-16
The effe­ctiveness of tele-rehabilitation for patients with multiple scle­rosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81
Long-term effi­cacy and safety of divo­zilimab during 2-year treatment of multiple scle­rosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96
A case of COVID-associated ence­phalopathy in a patient with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163
Opti­cal cohe­rence tomo­graphy angiography in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(2):63-70
Electroencephalography: features of the obtained data and its applicability in psychiatry. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):31-39
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42

Objective. To evaluate the diagnostic value of determination of free immunoglobulin light chains (IgG) in the debut of multiple sclerosis (MS). Material and methods. Data from 226 patients, including 111 patients with clinically isolated syndrome with conversion to multiple sclerosis within the first 2 years of the disease (group 1), 49 patients with clinically isolated syndrome who did not develop multiple sclerosis within the first 2 years of the disease (group 2), 20 patients with other inflammatory diseases of the central nervous system (group 3) were analyzed. The control group consisted of 46 patients with non-inflammatory diseases of the central nervous system. The clonality of immunoglobulins in the CSF, concentration of kappa and lambda free light chains and their ratio were studied. Results. Concentrations of free light chains were significantly higher in the first group in comparison with group 2 and the control group, but didn’t differ from group 3. In group 3, concentrations of free light chains were significantly higher compared to group 2 and controls. In oligoclonal-positive patients with clinically isolated syndrome (groups 1 and 2), concentrations of kappa and lambda free light chains were significantly higher than in oligoclonal-negative patients. The production of free light chains in patients from the first group was considerably higher than in group 2 regardless of the oligoclonal status. The concentration of kappa chains and quotient of kappa free light chains in the CSF had the best diagnostic characteristics. Their use, along with the evaluation of IgG clonality, reduced the risk of false-negative results by 50%. Regardless of other factors, elevated concentrations of kappa chains increase the likelihood of MS diagnosis by 9.718 times. Conclusion. The use of free light chains as a laboratory marker can increase the accuracy of MS diagnosis. These markers can help indirectly assess the risk of transformation of a clinically isolated syndrome into definite multiple sclerosis within the first 2 years of disease.

Keywords:

multiple sclerosis
clinically isolated syndrome
immunoglobulin free light chains
oligoclonal bands
biomarkers

Authors:

Nazarov V.D.

Tsentr rassejannogo skleroza i drugih demielinizirujuschih zabolevaniĭ Gorodskoĭ klinicheskoĭ bolnitsy №31, Sankt-Peterburg

Makshakov G.S.

Tsentr rassejannogo skleroza i drugih demielinizirujuschih zabolevaniĭ Gorodskoĭ klinicheskoĭ bolnitsy №31, Sankt-Peterburg

Mazing A.V.

First Saint-Petersburg Pavlov State Medical University, Saint-Petersburg

Surkova E.A.

GBOU VPO «Pervyj Sankt-Peterburgskij gosudarstvennyj meditsinskij universitet im. akad. I.P. Pavlova» Minzdrava Rossii, Sankt-Peterburg, Rossija

Krasnov V.S.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova, kafedra nevrologii s klinikoĭ;
Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova, Sankt-Peterburg

Shumilina M.V.

Akademicheskaia gruppa akad. RAMN A.A. Skoromtsa (Universitet Émori - Atlanta, SShA);
Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.P. Pavlova

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Evdoshenko E.P.

Sankt-Peterburgskoe GBUZ "Gorodskaia klinicheskaia bol'nitsa #31", Sankt-Peterburgskiĭ gorodskoĭ Tsentr rasseiannogo skleroza i autoimmunnykh zabolevaniĭ, Sankt-Peterburg

Lapin S.V.

Pavlov First St. Petersburg State Medical University, Russia, 197022, St. Petersburg, St. Leo Tolstoy 6/8

Emanuel’ V.L.

Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First Saint Petersburg State Medical University» of the Ministry of Healthcare of the Russia, Saint Petersburg, Russia

Skoromets A.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

List of references:

  1. Boyko AN, Favorova OO, Kulakova OG, Gusev EI. Epidemiology and etiology of multiple sclerosis. Edited by Gusev E.I., Zavalishin I.A., Boyko A.N. M. 2004. (In Russ.).
  2. Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin F, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson A, Waubant E, Weinshenker B, Wolinsky J. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology. 2011;69(2):292-302. doi:10.1002/ana.22366
  3. Vasconcelos C, Aurenção J, Thuler L, Camargo S, Alvarenga M, Alvarenga R. Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 2016;8:27-34. doi:10.1016/j.msard.2016.03.011
  4. Tintoré M, Rovira A, Brieva L, Grivé E, Jardí R, Borrás C, Montalban X. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Multiple Sclerosis. 2001;7(6):359-363. doi:10.1177/135245850100700603
  5. Edan G, Kappos L, Montalban X, Polman C, Freedman M, Hartung H, Miller D, Barkhof F, Herrmann J, Lanius V, Stemper B, Pohl C, Sandbrink R, Pleimes D. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT. Journal of Neurology, Neurosurgery & Psychiatry. 2014;85(11):1183-1189. doi:10.1136/jnnp-2013-306222
  6. Lapin S.V., Evdoshenko E.P. Laboratory methods for the diagnostics of multiple sclerosis and other neurologic diseases. Spravochnik zaveduyushchego KDL. 2011; 1: 22
  7. Makshakov GS, Lapin SV, Evdoshenko EP. Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis. Zh Nevrol Psikhiatr Im. S.S. Korsakova. 2016;116(2-2):14-20. (In Russ.). doi:10.17116/jnevro20161162214-20
  8. Villar L, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avşar T, Lapin S, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, Masterman D, García-Sánchez M, Coret F, Siva A, Evdoshenko E, Álvarez-Cermeño J, Bar-Or A. Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis. Annals of Neurology, 2014;76(2):231-240. doi:10.1002/ana.24190
  9. Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84:909-914. doi:10.1136/jnnp-2012-304695
  10. Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick J, Meier U, Marta M, Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeno J, Kleinova P, Horakova D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martinez A, Carra A, Salvetti M, Uccelli A, Torkildsen O, Myhr K, Galimberti D, Rejdak K, Lycke J, Frederiksen J, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli O, Vecsei L, Kieseier B, Hartung H, Villoslada P, Siva A, Saiz A, Tumani H, Havrdova E, Villar L, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintore M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan S, Giovannoni G. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis Journal. 2015;21(8):1013-1024. doi:10.1177/1352458514568827
  11. Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S, et al. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. Journal of Neuroimmunology. 2014;276:175-179. doi:10.1016/j.jneuroim.2014.08.003
  12. Nazarov VD, Lapin SV, Surkova EA, Evdoshenko EP, Makshakov GS, Totolian AA. Diagnostic and prognostic significance of intrathecal synthesis of immunoglobulin free light chains in multiple sclerosis. Medical Immunology (Russia)/Meditsinskaya Immunologiya. 2015;17:3:235-244. (In Russ.). doi:10.15789/1563-0625-2015-3-235-244
  13. Totolyan NA, Gotovchikov AA, Lapin SV, Maksimov IV, Kodzaeva AYu, Prakhova LN, Ilves AG, Skoromets AP, Totolyan AA, Skoromets AA. Intrathecal synthesis of immunoglobulins in diagnostics and differential diagnostics of multiple sclerosis. Zh Nevrol Psikhiatr Im. S.S. Korsakova. 2012;9(2):73-86. (In Russ.).
  14. Nakano T, Matsui M, Inoue I, Awata T, Katayama S, Murakoshi T. Free immunoglobulin light chain: Its biology and implications in diseases. Clinica Chimica Acta. 2011;412(11-12):843-849. doi:10.1016/j.cca.2011.03.007
  15. Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis. A consensus report. J Neurol Neurosurg Psychiatr. 1994;57:897-902.
  16. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis. Arch Neurol. 2005;62:865-870.
  17. Senel M, Tumani H, Lauda F, Presslauer S, Mojib-Yezdani R, Otto M, et al. Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis. PLoS ONE. 2014;9(4):88680. doi:10.1371/journal.pone.0088680
  18. Presslauer S, Milosavljevic D, Huebl W, Parigger S, Schneider-Koch G, Bruecke T. Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS. PLoS ONE. 2014;9(2):89945. doi:10.1371/journal.pone.0089945

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.